Clinical Trial Detail

NCT ID NCT02386826
Title INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements yes
Sponsors SCRI Development Innovations, LLC
Indications

glioblastoma multiforme

gliosarcoma

Therapies

Bevacizumab + Capmatinib

Age Groups: adult senior

Additional content available in CKB BOOST